David Holland is CMO at ALIMERA SCIENCES INC (ALIM). They have made 2 open-market trades across 1 company since 2013, most recently 2024-09-16.
CIK 0001489532
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $20K since 2021, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALIM | 108,880 | $603K |
Shares reported on the most recent Form 4, priced at the 2023-03-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALIM | BUY | 2021-11-03 | 2021-11-04 | $4.08 | $20K | +8.6% | -8.6% | -13.9% |
| ALIM | SELL · 10b5-1 | 2018-01-18 | 2018-01-19 | $1.20 | $31K | +0.0% | +7.7% | -4.3% |
| ALIM | SELL · 10b5-1 | 2018-01-16 | 2018-01-18 | $1.24 | $31K | -3.3% | +3.3% | -8.2% |
| ALIM | SELL · 10b5-1 | 2015-01-02 | 2015-01-06 | $5.56 | $28K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL · 10b5-1 | 2014-12-01 | 2014-12-03 | $5.71 | $29K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL · 10b5-1 | 2014-11-03 | 2014-11-05 | $5.34 | $27K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL · 10b5-1 | 2014-10-01 | 2014-10-02 | $5.26 | $26K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL · 10b5-1 | 2014-08-01 | 2014-08-04 | $5.64 | $28K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL · 10b5-1 | 2014-07-01 | 2014-07-02 | $6.02 | $30K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL · 10b5-1 | 2014-06-02 | 2014-06-04 | $5.73 | $29K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL · 10b5-1 | 2014-05-01 | 2014-05-02 | $5.93 | $30K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL · 10b5-1 | 2014-04-01 | 2014-04-03 | $8.01 | $80K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL · 10b5-1 | 2014-03-03 | 2014-03-05 | $6.84 | $68K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL | 2013-05-17 | 2013-05-20 | $4.13 | $124K | -20.2% | +0.0% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.